Mastering EU eCTD Submissions: Strategies for Compliance and Success
EU eCTD Submissions have become increasingly complex as regulatory standards continue to evolve across Europe. The filing of regulatory dossiers is no longer straightforward, with changing expectations from the European Medicines Agency and other health authorities.
What is UDI (Unique Device Identification)?
In the modern healthcare system, ensuring the safety and traceability of medical devices is extremely important. Unique Device Identification (UDI) is a global regulatory system designed to assign a unique code to every medical device. This system helps manufacturers, regulators, and healthcare providers easily identify and track devices throughout their lifecycle.
EU eCTD Submissions 2026: Key Updates from EMA
European regulatory environment is still kept changing, and the European Medicines Agency (EMA) has been proposing essential changes to the EU eCTD submissions. In the case of pharmaceutical and life sciences firms that focus on Europe, compliance is no longer a choice to make but a necessity to succeed in terms of timely approvals and penetrating the market.
eCTD Guidance for Marketing Authorisation and Post-Authorisation Applications in Europe: A 2026 Regulatory Perspective
Most of the regulatory processes in Europe are required to submit Electronic Common Technical Document (eCTD). Standardized electronic dossiers are required by the European Medicines Agency (EMA) and national competent authorities of the Marketing Authorisation Application (MAA) and the Post-Authorisation Application (PAA).
What is a Periodic Safety Update Report (PSUR)?
In the pharmaceutical industry, monitoring the safety of medicines does not stop after a drug is approved and marketed. Continuous safety evaluation is essential to identify potential risks and ensure patient protection. A Periodic Safety Update Report (PSUR) is a key pharmacovigilance document that provides updated safety information about a medicinal product during its lifecycle.